Congress probes med device payments

Should device makers retain surgeons as consultants? That's what the Senate Special Committee on Aging plans to discuss today at a hearing over some $221 million in payments five companies made to docs in 2007.

The companies--Zimmer Holdings, Biomet, Stryker, Smith & Nephew, and Johnson & Johnson's DePuy Orthopaedics--agreed to disclose those payments in September to settle government allegations that they violated anti-kickback laws. Four of the companies agreed to pay $310 million to settle kickback claims.

Sen. Herb Kohl, chair of the Senate committee, has proposed legislation that would mandate disclosure of the consulting payments.

- read the story in the Wall Street Journal

Suggested Articles

Pfizer’s Ibrance has met with success in breast cancer since breaking onto the scene in 2015. But its first foray into early breast cancer was a bust.

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.